Digital Sponsored Why AI transformation is really about people Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.
Market Access Is the next generation of Chinese biotech ready to go global... Will Chinese biotechs continue to transfer most ex-China rights, or retain their strongest assets and compete internationally themselves?
Market Access Sponsored From first approval to lasting value: What sets successful e... Approval may validate the science, but it does not secure commercial success. That outcome is determined by the decisions made before launch.
Market Access Pharma’s most expensive question is the last one asked Whether a drug can secure reimbursement is pharma's billion-dollar question, and the companies that succeed will be those that answer it sooner.
Sales & Marketing Beyond omnichannel: Why pharma commercialisation must shift ... We need to step away from the passive, broad concept of omnichannel and adopt a far more active, disciplined framework: omnideployment.
News Roche’s Genentech strikes $2.3bn deal for Hanmi obesity drug... Roche’s Genentech has agreed a deal worth up to $2.3 billion to develop and sell Hanmi Pharmaceutical’s experimental obesity drug HM17321.
News Astellas pays $285m for Audax cancer drug, and other deals Astellas takes an option on a cancer immunotherapy developed by Audax for up to $1.34bn, with Gilead and Teva also adding to their pipelines.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.